Jarrod Brodsky is an associate in the Governmental Practice in the firm's Washington, D.C. office.
Areas of Practice
Jarrod provides regulatory healthcare counsel as it relates to fraud and abuse, the Health Insurance Portability and Accountability Act (HIPAA), scope of practice, Medicare and Medicaid program reimbursement, and price transparency, with a particular focus on operational considerations related to the No Surprises Act.
Prior to joining Sheppard Mullin, Jarrod was a Health Law Fellow in the Office of the General Counsel of the Mid-Atlantic’s largest healthcare system where he advised on issues related to Stark Law, HIPAA/privacy matters, managed care contracting, and the 340B Drug Pricing Program.
Jarrod received his J.D. from Georgetown University Law Center, where he served on the board of Outlaw (LGBTQ+ organization) as well as Diversity Editor of The Georgetown Law Journal. While attending law school, Jarrod completed a judicial internship for the U.S. District Courts, Middle District of Florida. Jarrod also interned at:
- The U.S. Department of Health and Human Services, Office of the General Counsel, CMS Division;
- New York Legal Assistance Group, where he advocated for elderly New York Medicaid recipients; and
- Children’s Law Center, where he assessed utilizing Section 1115 Medicaid Waivers to improve mental health access and quality for youth in D.C.
Healthcare Law Blog Posts
- "HHS Issues Proposed Rule to Provide Clarity on Rights of Conscience in Healthcare," January 26, 2023
- "Don’t Let Drugs Bring You Down: The Importance of an Effective Drug Diversion Program," December 6, 2022
- "Final Rule Changes No Surprises Act Requirements," September 22, 2022
- "Eighth Circuit: In False Claims Act Cases Based On Kickback Violations, the Kickback Violation Must Be the “But For” Cause of the Items and Services Subject to the Claim," July 29, 2022
- "Supreme Court Saves Hospitals from $1.6B Cut to 340B Program," June 20, 2022
- "CMS Issues Contract Year 2023 Final Rule for Medicare Advantage Organizations and Prescription Drug Sponsors," May 16, 2022
- "Less is More: Brevity is the Soul of Wit," April 14, 2022
- "CMS’s Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs," January 10, 2022
- "News Flash: Last Minute Congressional Action Saves Physicians from a Nearly 10% Cut to Medicare Payments," December 10, 2021
- "Relief from Surprise Bills – Congress Passes the No Surprises Act What Providers and Insurers Need to Know," November 9, 2021
- "State, Federal, and Private Enforcement of Mental Health Parity Compliance," November 3, 2021
- "Congressional Action in the Face of Mounting Concerns Regarding Current and Future Physician Shortages," June 18, 2021
- "MITRE Corporation Outlines a Proposal for a Digital Health Revolution in New Report," June 4, 2021
- "CMS Proposes Repeal of Certain Cost Reporting Requirements from the IPPS Final Rule for 2021," May 21, 2021
- Hilton Daytona Beach Oceanfront, Daytona, FL, 04.17.2023
- Don’t Let Drugs Bring You Down: Get the Scoop on How to Effectively Prevent, Recognize, Investigate and Report Drug DiversionWebinar, 12.08.2022
- Webinar, 05.19.2022